Page last updated: 2024-12-06

molybdate ion

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

molybdate : A divalent inorganic anion obtained by removal of both protons from molybdic acid [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID24621
CHEMBL ID183648
CHEBI ID36264
MeSH IDM0322080

Synonyms (24)

Synonym
molybdate (moo42-), (t-4)-
[moo4](2-)
tetraoxidomolybdate(vi)
14259-85-9
CHEBI:36264
tetraoxidomolybdate(2-)
moo4-2
moo42-
molybdate
molybdate ion
NCGC00161827-01
chembl183648
bdbm50159781
dioxido(dioxo)molybdenum
molybdate ion (moo42-)
unii-o0l10e6352
o0l10e6352 ,
11116-47-5
molybdate (moo42-)
MEFBJEMVZONFCJ-UHFFFAOYSA-N
Q27104351
DTXSID001053337
moo42?
molybdate standard: moo4(-2) @ 1000 microg/ml in h2o

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"Accurate information on the chemical nature of soil phosphorus is essential for understanding its bioavailability and fate in wetland ecosystems."( Overestimation of organic phosphorus in wetland soils by alkaline extraction and molybdate colorimetry.
Newman, S; Reddy, KR; Turner, BL, 2006
)
0.33
"Aging reactions in soils can influence the lability and hence bioavailability of added metals in soils through their removal from labile pools into pools from which desorption is slow (non-labile pools)."( Aging effects on molybdate lability in soils.
Ajiboye, B; Kirby, JK; Ma, Y; McLaughlin, MJ, 2012
)
0.38

Dosage Studied

ExcerptRelevanceReference
"Eighteen ewes divided into two groups were dosed orally with CuSO4 in order to induce chronic Cu toxicity."( Intravenously administered tetra-thiomolybdate and the removal of copper from the liver of copper-loaded sheep.
Howell, JM; Kumaratilake, JS, 1989
)
0.28
" However, the dose-response curves for AHH induction by TCDD or benz(alpha)anthracene in A431 cells were shifted about one log unit to the right of the curves for Hepa-1 cells."( Characterization of the Ah receptor and aryl hydrocarbon hydroxylase induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin and benz(a)anthracene in the human A431 squamous cell carcinoma line.
Golas, CL; Harper, PA; Okey, AB, 1988
)
0.27
" The method is applicable for the assay of the four drugs under investigation in different dosage forms and the results are in good agreement with those obtained by the official method."( Spectrophotometric determination of ampicillin, dicluxacillin, flucloxacillin and amoxicillin antibiotic drugs: ion-pair formation with molybdenum and thiocyanate.
Mohamed, GG, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
molybdenum oxoanion
divalent inorganic anionAny inorganic anion with a valency of two.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (8)

PathwayProteinsCompounds
Metabolism14961108
Metabolism of vitamins and cofactors146155
Metabolism of water-soluble vitamins and cofactors102114
Molybdenum cofactor biosynthesis817
D-sorbitol biosynthesis I115
molybdenum cofactor biosynthesis618
phytate degradation I316
molybdenum cofactor biosynthesis1823
phytate degradation I021
NAD salvage pathway III (to nicotinamide riboside)213
molybdenum cofactor biosynthesis I013

Research

Studies (695)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990156 (22.45)18.7374
1990's137 (19.71)18.2507
2000's170 (24.46)29.6817
2010's179 (25.76)24.3611
2020's53 (7.63)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.97 (24.57)
Research Supply Index6.57 (2.92)
Research Growth Index4.60 (4.65)
Search Engine Demand Index33.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.14%)5.53%
Reviews16 (2.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other694 (97.61%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]